New FDA-Approved Treatment for RKD

The FDA has approved Gazyva® (obinutuzumab) for adults and children ages 2 and older with idiopathic nephrotic syndrome that began in childhood and is frequently relapsing (FRNS) or steroid-dependent (SDNS). More information coming soon. Please visit our Patient Navigation tool for support.

en_US EN
en_US EN es_MX ES

RESOURCES

/

FIND A SPECIALIST

/

CONTACT

Back to Clinical Trials
Home / Managing RKD / Clinical Trials / PODOMOUNT-Basket

PODOMOUNT-Basket

I'M INTERESTED

Brief Description

The PODOMOUNT-Basket study is evaluating whether an investigational once daily oral medication called Apecotrep reduces the amount of protein in the urine in adult patients with Alport syndrome, secondary FSGS, membranous nephropathy (MN), and in both adults and adolescents with minimal change disease (MCD).

Trial Physician / Study Coordinator

Yvette Martinez

Email Phone
Estimated Enrollment

132

Estimated End Date

2/9/2028

Trial is for people with

Alport syndrome, primary membranous nephropathy, primary minimal change disease, secondary FSGS, as well as FSGS of undetermined ...

Study Goal

To learn more about the safety of apecotrep and determine if it may help people with four rare kidney diseases—primary minimal change ...

What is involved for the patient?

You will receive either study drug (apecotrep) or placebo for 20 weeks. The randomization will be 2:1, meaning twice as many patients ...

About the drug or intervention

Apecotrep is a once daily non-immunosuppressant oral medication that is designed to protect podocytes, the cells which keep protein ...

Find other locations for this trial:
Boca Raton, FL

I'm Interested in this Trial

"*" indicates required fields

Your name*
This field is hidden when viewing the form
Your contact information will be sent to a team at
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
Have you ever had a kidney transplant?*
Are you currently on dialysis?*
Did you have a biopsy to confirm your diagnosis?*
Are you currently on the transplant wait-list?*
This field is hidden when viewing the form
This field is hidden when viewing the form
Interested in CT
Disclaimer

By clicking the submit button, your information and results will be sent to the study coordinator. Submitting the form does not guarantee enrollment but helps determine potential eligibility and connects you with the study team. Please consult your healthcare provider before pursuing participation in any trial.

Frequently Asked Questions

Nephrotic Syndrome is not a disease itself, but rather a group of signs and symptoms that result from damage in the part of the kidney that filters blood (glomeruli).

Common symptoms include:

  • Foamy urine (called proteinuria) caused by protein “spilling” into the urine
  • Severe swelling in parts of the body, most noticeably around the eyes, hands, feet, and abdomen (called edema)
  • Weight gain due to a buildup of extra fluid
  • Fatigue
  • Loss of appetite
  • Low levels of protein in the blood (hypoalbuminemia)
  • Higher than normal fat and cholesterol levels in the blood (hyperlipidemia)

Nephrotic Syndrome can typically be diagnosed with a urine test.

Share this

Nephrotic Syndrome can be “primary” or “secondary” in nature.

Diseases that affect only the kidneys are called primary causes of Nephrotic Syndrome. Doctors often call these diseases “idiopathic,” which means that they arise from an unknown cause. Some of these diseases include:

  • Minimal Change Disease (MCD) – most common in children
  • Focal Segmental Glomerulosclerosis (FSGS)
  • Membranous Nephropathy (MN) – most common in adults
  • IgA Nephropathy (IgAN)

Secondary Nephrotic Syndrome is caused by an underlying, systemic condition like diabetes, lupus, HIV, and others.

Share this

Clinical studies are any studies that involve people. There are two main types: observational and interventional. In an observational trial, researchers track health outcomes over time in groups of participants to look for patterns that help us better understand a disease. In an interventional trial, participants receive specific interventions, which can include new treatments or behavorial changes (e.g., diet changes). To learn more about clinical research, please visit the NephCure website.

Share this
See other frequently asked questions
NephCure Logo

INTRO TO RKD

Overview
Types of RKD
Navigating New Diagnosis
Pediatric Care
End-Stage Kidney Disease

SUPPORT

Patient Navigation Services
Online Patient Community
Patient Stories
Support Groups
Resources

MANAGING RKD

Find a Specialist
Clinical Trials
Treatment Options
RKD & Mental Health
Diet & Nutrition
Genetic Testing

LEGAL

Careers
Privacy Policy
Policies & Disclaimers
Financials

ABOUT US

Our Impact
What We Do
Team
Current Partnerships
News
Contact Us

GET INVOLVED

Volunteer
Events
Advocacy
Find your Local Community
Ways to Give

Our Mission

NephCure’s mission is to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome possible.

Find Us On

NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.